CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LRMR — Larimar Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$654,039
+$36,389 QoQ
Shares Held
145,342
-10.3% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. LRMR ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in LRMR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $654,039 | 145,342 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $617,650 | 162,113 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $523,624 | 162,113 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $321,946 | 111,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $215,982 | 100,457 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $484,241 | 125,127 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $819,581 | 125,127 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $928,688 | 128,095 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $630,038 | 83,009 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $335,621 | 73,763 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $291,363 | 73,763 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $230,878 | 73,763 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $68,570 | 15,137 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $62,515 | 15,137 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||